WALTHAM, Mass. / Feb 21, 2024 / Business Wire / Revvity, Inc. (NYSE: RVTY) today announced it will present at the following investor conferences in February and March 2024:
Citi's 2024 Unplugged MedTech and Life Sciences Access Day - New York City, NY
Thursday, February 29, 2024
8:00 a.m. ET - Max Krakowiak, senior vice president and chief financial officer
TD Cowen 44th Annual Health Care Conference – Boston, MA
Monday, March 4, 2024
9:10 a.m. ET - Prahlad Singh, president and chief executive officer
Raymond James 45th Annual Institutional Investors Conference – Orlando, FL
Tuesday, March 5, 2024
9:15 a.m. ET - Max Krakowiak
Barclays Global Healthcare Conference – Miami, FL
Tuesday, March 12, 2024
9:30 a.m. ET - Prahlad Singh
KeyBanc 4th Annual Life Sciences & MedTech Investor Forum - Virtual
Wednesday, March 20, 2024
9:00 a.m. ET– Yves Dubaquie, senior vice president, diagnostics and Steve Willoughby, senior vice president, investor relations & ESG
Attendees will receive an update on the Company and its strategic priorities.
Live audio webcasts will be available on the Events section of the Company’s website. Replays of the presentations will be posted on the Revvity Investor Relations website after the events and will be available for at least 30 days.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.
| Last Trade: | US$96.77 |
| Daily Change: | 0.50 0.52 |
| Daily Volume: | 1,365,035 |
| Market Cap: | US$10.970B |
December 16, 2025 November 10, 2025 October 28, 2025 October 27, 2025 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
